These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 22710269)

  • 1. The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila.
    Pizzo AB; Karam CS; Zhang Y; Yano H; Freyberg RJ; Karam DS; Freyberg Z; Yamamoto A; McCabe BD; Javitch JA
    Mol Psychiatry; 2013 Jul; 18(7):824-33. PubMed ID: 22710269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization.
    Runegaard AH; Dencker D; Wörtwein G; Gether U
    Neuropharmacology; 2019 Dec; 161():107663. PubMed ID: 31173760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
    Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic Ric GTPase activity impacts amphetamine sensitivity and sleep quality in a dopamine transporter-dependent manner in Drosophila melanogaster.
    Fagan RR; Kearney PJ; Luethi D; Bolden NC; Sitte HH; Emery P; Melikian HE
    Mol Psychiatry; 2021 Dec; 26(12):7793-7802. PubMed ID: 34471250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A network of phosphatidylinositol (4,5)-bisphosphate (PIP
    Belovich AN; Aguilar JI; Mabry SJ; Cheng MH; Zanella D; Hamilton PJ; Stanislowski DJ; Shekar A; Foster JD; Bahar I; Matthies HJG; Galli A
    Mol Psychiatry; 2021 Aug; 26(8):4417-4430. PubMed ID: 31796894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.
    Rickhag M; Owens WA; Winkler MT; Strandfelt KN; Rathje M; Sørensen G; Andresen B; Madsen KL; Jørgensen TN; Wörtwein G; Woldbye DPD; Sitte H; Daws LC; Gether U
    J Biol Chem; 2013 Sep; 288(38):27534-27544. PubMed ID: 23884410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
    Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
    Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.
    Hamilton PJ; Belovich AN; Khelashvili G; Saunders C; Erreger K; Javitch JA; Sitte HH; Weinstein H; Matthies HJG; Galli A
    Nat Chem Biol; 2014 Jul; 10(7):582-589. PubMed ID: 24880859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.
    Mergy MA; Gowrishankar R; Gresch PJ; Gantz SC; Williams J; Davis GL; Wheeler CA; Stanwood GD; Hahn MK; Blakely RD
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4779-88. PubMed ID: 25331903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
    Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
    Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein βγ subunits play a critical role in the actions of amphetamine.
    Mauna JC; Harris SS; Pino JA; Edwards CM; DeChellis-Marks MR; Bassi CD; Garcia-Olivares J; Amara SG; Guajardo FG; Sotomayor-Zarate R; Terminel M; Castañeda E; Vergara M; Baust T; Thiels E; Torres GE
    Transl Psychiatry; 2019 Feb; 9(1):81. PubMed ID: 30745563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism.
    Khoshbouei H; Wang H; Lechleiter JD; Javitch JA; Galli A
    J Biol Chem; 2003 Apr; 278(14):12070-7. PubMed ID: 12556446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K signaling supports amphetamine-induced dopamine efflux.
    Lute BJ; Khoshbouei H; Saunders C; Sen N; Lin RZ; Javitch JA; Galli A
    Biochem Biophys Res Commun; 2008 Aug; 372(4):656-61. PubMed ID: 18510945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
    Jones SR; Gainetdinov RR; Wightman RM; Caron MG
    J Neurosci; 1998 Mar; 18(6):1979-86. PubMed ID: 9482784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
    Goodwin JS; Larson GA; Swant J; Sen N; Javitch JA; Zahniser NR; De Felice LJ; Khoshbouei H
    J Biol Chem; 2009 Jan; 284(5):2978-2989. PubMed ID: 19047053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
    Khoshbouei H; Sen N; Guptaroy B; Johnson L'; Lund D; Gnegy ME; Galli A; Javitch JA
    PLoS Biol; 2004 Mar; 2(3):E78. PubMed ID: 15024426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action.
    Karam CS; Javitch JA
    Adv Pharmacol; 2018; 82():205-234. PubMed ID: 29413521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca
    Støier JF; Konomi-Pilkati A; Apuschkin M; Herborg F; Gether U
    J Biol Chem; 2023 Aug; 299(8):105063. PubMed ID: 37468107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate.
    Schrantee A; Tremoleda JL; Wylezinska-Arridge M; Bouet V; Hesseling P; Meerhoff GF; de Bruin KM; Koeleman J; Freret T; Boulouard M; Desfosses E; Galineau L; Gozzi A; Dauphin F; Gsell W; Booij J; Lucassen PJ; Reneman L
    PLoS One; 2017; 12(2):e0172776. PubMed ID: 28241065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.